Royal Bank of Canada Purchases 437,810 Shares of Cemex SAB de CV (NYSE:CX)

Royal Bank of Canada boosted its position in Cemex SAB de CV (NYSE:CX) by 59.6% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,172,172 shares of the construction company’s stock after acquiring an additional 437,810 shares during the period. Royal Bank of Canada owned 0.08% of Cemex SAB de CV worth $4,970,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Virtus ETF Advisers LLC purchased a new position in Cemex SAB de CV during the 2nd quarter valued at about $26,000. Golden State Wealth Management LLC raised its holdings in shares of Cemex SAB de CV by 121.9% during the second quarter. Golden State Wealth Management LLC now owns 7,281 shares of the construction company’s stock valued at $30,000 after acquiring an additional 4,000 shares in the last quarter. Oppenheimer & Co. Inc. bought a new position in shares of Cemex SAB de CV during the second quarter valued at approximately $62,000. Jefferies Group LLC bought a new position in shares of Cemex SAB de CV during the second quarter valued at approximately $76,000. Finally, Private Advisor Group LLC bought a new position in shares of Cemex SAB de CV during the second quarter valued at approximately $88,000. Institutional investors and hedge funds own 30.87% of the company’s stock.

A number of equities analysts recently commented on the company. Zacks Investment Research downgraded Cemex SAB de CV from a “hold” rating to a “sell” rating in a report on Monday, October 7th. Santander cut Cemex SAB de CV from a “buy” rating to a “hold” rating in a research note on Monday, July 15th. ValuEngine raised Cemex SAB de CV from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, HSBC cut Cemex SAB de CV from a “buy” rating to a “hold” rating in a research note on Wednesday, September 11th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company’s stock. Cemex SAB de CV currently has an average rating of “Hold” and a consensus target price of $6.00.

NYSE CX opened at $4.07 on Friday. The stock’s 50-day moving average price is $3.77 and its 200-day moving average price is $4.07. The company has a quick ratio of 0.53, a current ratio of 0.74 and a debt-to-equity ratio of 0.83. Cemex SAB de CV has a 52 week low of $2.82 and a 52 week high of $6.53. The company has a market capitalization of $5.78 billion, a P/E ratio of 11.63, a price-to-earnings-growth ratio of 0.80 and a beta of 1.44.

Cemex SAB de CV (NYSE:CX) last announced its earnings results on Thursday, July 25th. The construction company reported $0.06 EPS for the quarter. The firm had revenue of $3.52 billion during the quarter. Cemex SAB de CV had a return on equity of 1.75% and a net margin of 2.37%. Research analysts anticipate that Cemex SAB de CV will post 0.31 EPS for the current year.

Cemex SAB de CV Company Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, clinker, and other construction materials. The company also offers various complementary construction products, including asphalt products; concrete blocks and roof tiles; architectural products; concrete pipes for storm and sanitary sewers applications; and other precast products comprising rail products, concrete floors, box culverts, bridges, drainage basins, barriers, and parking curbs.

Featured Article: Dead Cat Bounce

Want to see what other hedge funds are holding CX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cemex SAB de CV (NYSE:CX).

Institutional Ownership by Quarter for Cemex SAB de CV (NYSE:CX)

Receive News & Ratings for Cemex SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cemex SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.